DARTMOUTH-HITCHCOCK MEDICAL CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1983-01-01

Employees: 10K

Market Cap: -

Website: http://www.dartmouth-hitchcock.org

Clinical Trials

Efficacy of Inhaling Bronchodilator Medications in Chronic Obstructive Pulmonary Disease

Not Applicable

Completed

Conditions: Chronic Obstructive Pulmonary Disease

Interventions: Drug: arformoterol
Drug: salmeterol

First Posted Date: 2011-07-12

Last Posted Date: 2013-08-07

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Target Recruit Count: 20

Registration Number: NCT01391559

Locations: 🇺🇸
Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States

Protocol to Obtain Blood and Bone Marrow Samples for Myeloma Research

Terminated

Conditions: Multiple Myeloma

First Posted Date: 2011-06-27

Last Posted Date: 2018-04-25

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Target Recruit Count: 29

Registration Number: NCT01382615

Locations: 🇺🇸
Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States

Effect of Ketoconazole on Breathlessness

Phase 4

Completed

Conditions: Chronic Obstructive Pulmonary Disease

Interventions: Drug: ketoconazole
Drug: inert powder

First Posted Date: 2011-06-22

Last Posted Date: 2018-06-01

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Target Recruit Count: 20

Registration Number: NCT01378520

Locations: 🇺🇸
Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States

Helping Patients With Spinal Stenosis Make a Treatment Decision: A Randomized Study Assessing The Benefits of Health Coaching

Not Applicable

Completed

Conditions: Spinal Stenosis

Interventions: Other: Usual Care
Behavioral: Coaching

First Posted Date: 2010-12-21

Last Posted Date: 2013-08-05

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Target Recruit Count: 199

Registration Number: NCT01263678

Locations: 🇺🇸
Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States

Study of Palliative Care Intervention for Advanced Cancer Patients and Their Caregivers -Educate Nurture Advise Before Life Ends (ENABLE III)

Not Applicable

Completed

Conditions: Advanced Cancer

Interventions: Behavioral: Early palliative care intervention
Behavioral: Later entry group

First Posted Date: 2010-11-22

Last Posted Date: 2014-01-03

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Target Recruit Count: 360

Registration Number: NCT01245621

Locations: 🇺🇸
Providence VA Medical Center, Providence, Rhode Island, United States
🇺🇸
Dartmouth-Hitchcock Medical Center - Lebanon, Lebanon, New Hampshire, United States
🇺🇸
Dartmouth-Hitchcock Clinic - Manchester, Manchester, New Hampshire, United States

and more 4 locations

Bendamustine and Rituximab Followed by 90-yttrium (Y) Ibritumomab Tiuxetan for Untreated Follicular Lymphoma

Phase 2

Completed

Conditions: Lymphoma, Follicular

Interventions: Drug: Bendamustine
Drug: Rituximab
Radiation: Y-90 ibritumomab

First Posted Date: 2010-11-04

Last Posted Date: 2021-05-18

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Target Recruit Count: 39

Registration Number: NCT01234766

Locations: 🇺🇸
Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States
🇺🇸
Maine Center for Cancer Medicine, Scarborough, Maine, United States
🇺🇸
Duke University Medical Center, Durham, North Carolina, United States

and more 1 locations

Participation Restrictions in Breast Cancer Survivors

Not Applicable

Completed

Conditions: Breast Cancer

Interventions: Behavioral: Behavioral activation/problem-solving (BA/PS)

First Posted Date: 2010-10-21

Last Posted Date: 2014-12-19

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Target Recruit Count: 24

Registration Number: NCT01225328

Locations: 🇺🇸
Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States

A Study of Quetiapine and Mirtazapine for the Treatment of Alcohol Dependency

Phase 2

Completed

Conditions: Alcohol Dependence

Interventions: Drug: Quetiapine fumarate extended release (Quetiapine XR)
Drug: Mirtazapine

First Posted Date: 2010-07-20

Last Posted Date: 2018-04-09

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Target Recruit Count: 20

Registration Number: NCT01165541

Locations: 🇺🇸
Dartmouth Medical School Department of Psychiatry's Addition Research Center, Bedford, New Hampshire, United States
🇺🇸
Dartmouth Medical School Department of Psychiatry's Addiction Research Center, Hanover, New Hampshire, United States

Erlotinib (Tarceva) and Bexarotene (Targretin) Oral Capsules in Advanced Cancers of the Aerodigestive Tract

Phase 1

Completed

Conditions: Advanced, Malignant Aerodigestive Tract Tumor (Lung, Head and Neck and Esophagus)

Interventions: Drug: Bexarotene (Targretin®)
Drug: Erlotinib (Tarceva™)

First Posted Date: 2010-05-05

Last Posted Date: 2023-10-18

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Target Recruit Count: 24

Registration Number: NCT01116622

Locations: 🇺🇸
Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States

The Neuroeconomics of Behavioral Therapies for Adolescent Substance Abuse

Completed

Conditions: Adolescent Substance Use

First Posted Date: 2010-03-26

Last Posted Date: 2018-03-19

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Target Recruit Count: 51

Registration Number: NCT01093898

Locations: 🇺🇸
Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy